Henry Schein, Inc.

Organisation

135 Duryea Road, Melville, NY, United States, 11747

Headquarters

25000

Employees

Wholesale Trade

Industry

Stanley Bergman

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Price

Target

Henry Schein, Inc. (HSIC) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Henry Schein, Inc. (HSIC) share price will touch around $89.79 in next 12-months.

Currently 21 wall-street analysts regularly analyze the financials of Henry Schein, Inc. on a frequent basis to provide recommendations along with target share price. 21 analysts offering 12-month price forecasts for Henry Schein, Inc. (HSIC) have a share price target of $89.79. This median of share price forecast represents a 19.32% upside from the latest price of $75.25 as on 17.03.26.

Henry Schein, Inc. (HSIC) Share Price Forecast

Home

US Stocks

Henry Schein, Inc. (HSIC)

Henry Schein, Inc. Stock Forecast

Henry Schein, Inc. Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Henry Schein, Inc. (HSIC): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Henry Schein, Inc.'s share price and its median forecast price. As on 17.03.26, the difference is -5.84%

Henry Schein, Inc. Forecast and Target Price

Henry Schein, Inc. (HSIC) Share Price Forecast

Henry Schein, Inc. (HSIC) Price vs Consensus Price Target

Henry Schein, Inc. (HSIC) Share Price Forecast v/s Share Price Today

Henry Schein, Inc. (HSIC): Difference between Current Price & Median Forecasted Price

Henry Schein, Inc. (HSIC) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price